Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Teqqa is a healthcare technology company specializing in antimicrobial stewardship and infectious disease data analytics. The company provides a cloud-based platform, Teqqa Precision, which helps hospitals and health systems optimize antibiotic use and track resistance patterns. By integrating with electronic health records, Teqqa's solutions offer real-time insights and decision support for clinicians and pharmacists to improve patient outcomes. The platform facilitates compliance with regulatory requirements and helps reduce the spread of multi-drug resistant organisms. In 2020, Teqqa was acquired by Wolters Kluwer Health to enhance its clinical surveillance and infectious disease portfolio. Its technology is now a key component of the Sentri7 clinical surveillance suite, serving healthcare providers globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TEQQA.